Paper31347149
Pharmacology of bisphosphonates in pain.
Tzschentke TM. Br J Pharmacol, 2021. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Pharmacology of bisphosphonates in pain. Papers, record 31347149. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31347149
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chronic Pain | Major topic |
| Diphosphonates | Major topic |
| Animals |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42491984 | Zoledronic acid produces analgesia by inhibiting the transient receptor potential vanilloid 1 (TRPV1) channel. | Pain Rep | 2026 | https://conductscience.org/library/papers/42491984 | PubMed |
| 41737302 | Intravenous Pamidronate in Persistent Complex Regional Pain Syndrome (CRPS): A Retrospective Observational Study on Effectiveness and Tolerability. | J Pain Res | 2026 | https://conductscience.org/library/papers/41737302 | PubMed |
| 41599114 | Pharmacological Management of Cancer Pain: Advances in Treatment Strategies and Drug Delivery Systems. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41599114 | PubMed |
| 41341143 | Comparative Effects of Minodronate and Alendronate on Low Back Pain in Postmenopausal Osteoporosis and Age Influence: A Head-to-Head, Randomized Clinical Trial. | Clin Interv Aging | 2025 | https://conductscience.org/library/papers/41341143 | PubMed |
| 40634658 | Pain in Osteoporosis: Current and Future Strategies. | Drugs Aging | 2025 | https://conductscience.org/library/papers/40634658 | PubMed |
| 40372122 | Transient osteoporosis of the hip and fatty liver disease: Case report and pathogenic hypothesis. | J Int Med Res | 2025 | https://conductscience.org/library/papers/40372122 | PubMed |
| 39323655 | Pamidronate for pain in adult chronic nonbacterial osteitis: protocol of a randomized, double-blind, placebo-controlled trial. | JBMR Plus | 2024 | https://conductscience.org/library/papers/39323655 | PubMed |
| 39257325 | 10. Complex regional pain syndrome. | Pain Pract | 2025 | https://conductscience.org/library/papers/39257325 | PubMed |
| 38799611 | The challenge of pharmacotherapy for musculoskeletal pain: an overview of unmet needs. | Ther Adv Musculoskelet Dis | 2024 | https://conductscience.org/library/papers/38799611 | PubMed |
| 38627292 | Neuropathic and Nociplastic Pain Profiles are Common in Adult Chronic Nonbacterial Osteitis (CNO). | Calcif Tissue Int | 2024 | https://conductscience.org/library/papers/38627292 | PubMed |
| 38626145 | Clodronate disodium does not produce measurable effects on bone metabolism in an exercising, juvenile, large animal model. | PLoS One | 2024 | https://conductscience.org/library/papers/38626145 | PubMed |
| 38585006 | Comparison of the relative diagnostic performance of 68Ga-DOTA-IBA and 18F-NaF for the detection of bone metastasis. | Front Oncol | 2024 | https://conductscience.org/library/papers/38585006 | PubMed |
| 36569491 | Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension study. | Ther Adv Musculoskelet Dis | 2022 | https://conductscience.org/library/papers/36569491 | PubMed |
| 35370739 | Bisphosphonates Targeting Ion Channels and Musculoskeletal Effects. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35370739 | PubMed |
| 35247200 | From a Symptom-Based to a Mechanism-Based Pharmacotherapeutic Treatment in Complex Regional Pain Syndrome. | Drugs | 2022 | https://conductscience.org/library/papers/35247200 | PubMed |
| 34924556 | Antibody-induced pain-like behavior and bone erosion: links to subclinical inflammation, osteoclast activity, and acid-sensing ion channel 3-dependent sensitization. | Pain | 2022 | https://conductscience.org/library/papers/34924556 | PubMed |
| 34881273 | Does Bisphosphonate Increase the Sclerosis of Tibial Subchondral Bone in the Progression of Knee Osteoarthritis-A Propensity Score Matching Cohort Study Based on Osteoarthritis Initiative. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34881273 | PubMed |
| 34215993 | Bisphosphonates, Bone and Joint Pain. | Curr Osteoporos Rep | 2021 | https://conductscience.org/library/papers/34215993 | PubMed |
| 33799992 | The Rationale for the Intra-Articular Administration of Clodronate in Osteoarthritis. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33799992 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31347149
GET https://conductscience.org/api/papers/v1/31347149/authors